Medmonk
Explains primary non-adherence and argues that cost, coverage barriers, lack of transparency, and logistics prevent many new prescriptions from ever becoming treatment; positions Medmonk as a way to reduce drop-off at the point of access.
A tool for pharmacists to find funding for patients who are unable to…
Company research
Public company, workplace, funding, and market signals
Overview
Medmonk is a B2B pharma market access and patient support platform that helps specialty and rare-disease brands accelerate patient enrollment, automate copay and hub workflows, and manage the access journey from prescription to adherence.
Primary product
Pharma market access platform for copay, hub, and patient support workflows
Founded
2012
Headquarters
Itasca, Illinois, United States (official site; LinkedIn company page also lists Milpitas, California)
Team size
10-20
Industry
Pharmaceutical Manufacturing
Sub-industry
pharma market access / patient support software
Offices
450 E Devon Ave, Suite 175, Itasca, IL 60143, USA
Milpitas, California, United States (LinkedIn company page)
Business model
B2B SaaS
enterprise services
hub services
copay assistance administration
patient support program management
Funding
Stage
Seed
Total raised
$275.3K
Latest round
Seed · Oct 2016
Latest amount
$150.3K
People & investors
Leadership
Chief Executive Officer
Chief Product Officer
Chief Medical Officer
Chief Operating Officer
Executive Vice President, Client Services
Director of Implementation & Accounts
Director of Client Services
Work & culture
Public careers language emphasizes a collaborative, growth-oriented, creativity- and innovation-driven environment; the company also presents itself as technology-first and mission-driven around patient access.
Compensation
No public salary bands or compensation philosophy were disclosed on the reviewed public pages.
Product & market
Pricing
Custom enterprise pricing / quote-based B2B contracts
Differentiators
- —Claimed 98% U.S. pharmacy and buy/bill network coverage
- —<3 second point-of-sale copay enrollment
- —Automated hub and prior-authorization workflows
- —Real-time brand analytics and ROI reporting
- —FHIR-compliant integrations without rip-and-replace
- —SOC 2 and HIPAA compliant
- —Rare disease and specialty therapy focus
- —7-year average brand partnership retention
Technology
FHIR-compliant APIs
SOC 2
HIPAA
GDPR-aligned security
point-of-sale copay adjudication
AI-powered prior authorization and PAP workflows
intelligent CRM and case management
real-time brand analytics dashboards
predictive adherence analytics
EHR integrations
CRM integrations
pharmacy system integrations
connected pharmacy network
Customers
pharma brands
market access leaders
brand and commercial teams
hub operators
specialty pharmacies
rare disease brands
pharmaceutical manufacturers
healthcare providers
Competitors
Omnicell
Alto
Medisafe
Wellth
Cureatr
Phil
Proteus Digital Health
Scale & contact
Estimated revenue
$10M-$20M
Latest news
Medmonk
Focuses on the gap between diagnosis and treatment start in rare disease, emphasizing prior authorization, benefits investigation, specialty-pharmacy coordination, affordability, and handoff leakage.
Medmonk
Frames financial access as a digital-health workflow problem and highlights integrated benefit verification, prior authorization management, and financial assistance workflows to reduce abandonment.
Medmonk
Argues that pharmacy logistics alone do not solve access; delays still occur in intake quality, documentation readiness, appeals, funding coordination, and HUB-to-specialty-pharmacy handoffs.
Medmonk
Describes copay cards, charitable foundations, and patient-assistance programs for expensive specialty drugs, and explains how Medmonk helps automate eligibility, enrollment, and prior authorization support.
Jobs and careers at Medmonk
0 jobs at Medmonk
No open positions
Check back later for new openings